The Centre for Commercialization of Regenerative Medicine (CCRM) is a not-for-profit organization that supports the development of regenerative medicine technologies and cell and gene therapies. It aims to bridge the commercialization gap between research and marketed products by providing business, technical, and manufacturing expertise to companies in the field.

Centre for Commercialization of Regenerative Medicine (CCRM)

MaRS Discovery District

Regenerative Medicine (RM), which aims to harness the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs, has the promise to treat, manage and perhaps cure some of the most devastating and costly diseases in the world today.

Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and engineers have come together to form CCRM, a leader in developing and commercializing regenerative medicine and cell therapy technologies. CCRM formally launched on June 14, 2011.

CCRM supports the development and commercialization of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy. 


CCRM

We are very pleased to share our 2023 #AnnualReport – Future Ready. We hope you will read it and share it. You can find it on our website: https://lnkd.in/gE8_Cxf

Peruse the pages to read about our partnerships, projects, portfolio companies,  people (like our terrific Board of Directors) and progress. 

Shoutouts (and thanks!): Networks of Centres of Excellence, Government of Canada, OmniaBio, McMaster Innovation Park, CCRM Nordic, CCRM Australia, Canadian Advanced Therapies Training Institute, University of Toronto, Centre de production de produits biologiques (CPPB) inc. / Biologics Manufacturing Centre (BMC) Inc., Jim Wilson, Peter Zandstra, McMaster University, Mohawk College, Catamaran Bio, Ontario Veterinary College, University of Guelph, The University of Queensland, Multiplex, Visions of Science , Vinnova, GoCo Health Innovation City, Glenn MacLean, Sarah Lepage, Medicine by Design - University of Toronto, Stem Cell Network and more!!! 

Join us at the Building a Biotech Venture Pitch Competition to cheer on 6 trainee-led entrepreneurial teams as they showcase their innovative technologies for a chance to win $25k or $10k in funding. Held in person at the William Doo Auditorium, 45 Willcocks St., March 27, 3-5pm. Learn more: https://lnkd.in/gqjnK6YV

It's #rarediseaseday and we have the topic covered with lots of interesting blogs related to rare diseases, treatments, advances and more. Pulled from the archives, you can find them here: https://lnkd.in/geSZtyDb

Are you on the path to #commercialization with your medical product? Blogger Laine B. recommends you develop a #communicationstrategy and shares five #tips. Shoutout to Glenn MacLean and #TMM2023 (Stem Cell Network)

https://lnkd.in/gHgVeWZN #pr #publicrelations #scicomm 

CA:CCRM

Centre for Commercialization of Regenerative Medicine (CCRM)